I J, male, aged 18. Schoolboy History: In August 1971 he developed patchy erythematous plaques on the left side of the neck. These remained stationary for 2-3 months, and then spread rapidly to give extensive areas of cedematous, erythematous and tender skin on the left side of the body. By May 1972 he had gross deformity of the left hand and forearm with muscle wasting. The disease was still predominantly left-sided, with the occasional patch on the right arm and side of the face and neck. He suffered from gross fatigue. There was no Raynaud's phenomenon and no dysphagia.
On examination: Extensive scleroderma on left side of body with underlying wasting of muscles, especially marked in the left forearm. There are tendon contractures around the left wrist. Small patches of scleroderma are present on the right forearm and the right side of the face and neck. There is also a small area of scarring alopecia (Figs 1, 2 and 3). Skin biopsy showed the changes of acute scleroderma, with the collagen bundles of the pars reticularis thickened, the interfascicular spaces narrow and a small round cell infiltrate in the deep dermis. Progress and treatment: Because of the worsening of his condition and the development of contractures he was put on prednisolone 10 mg four times a day in May 1972 and this was gradually reduced over the next six months. He has been off steroids for one month. The disease has not progressed since May 1972.
Investigations

Comment
This boy's case is unusual. Onset was acute and the process rapidly extended to give a predominantly left-sided scleroderma with myositis affecting the muscles underlying the involved skin. Winkelmann (1971) gives the name 'sclerodermatomyositis' to this condition and puts it under systemic sclerosis. However, we have found no evidence of systemic sclerosis in our patient and feel that he has an acute linear morphoea with myositis and that it may well have 'burnt itself out'. Winkelmann (1971) collected 27 cases of sclerodermatomyositis; 13 had a positive ANF and 12 of these were of the 'speckled' pattern. In Rowell's series (1967) , of 48 patients with systemic sclerosis 32 had a positive ANF and the homogeneous pattern was the most common, as in our patient. Only 3 out of 20 patients with morphoea had a positive ANF. The nucleolar pattern is less Muscle wasting is seen common but occurs more often in systemic sclerosis than in any other condition (Rowell 1968) .
In a review of 727 patients with systemic sclerosis Tuffanelli & Winkelmann (1961) found a positive LE cell test in only 5 patients, all women; only one of these 5 had sclerodermatomyositis.
Our patient has a raised IgG, which is a common finding in scleroderma (Winkelmann 1971) . He also has a raised IgM, which is unusual, and a small IgG paraprotein band. Oka (1969) described a boy aged 14 with unilateral scleroderma and marked subcutaneous atrophy; he had an IgM paraprotein band, a positive ANF and cryoglobulins.
In the series reported by Christiansen & Dorsey (1956) , of 235 patients with localized scleroderma 108 were in linear form of whom 12 had both an upper and a lower limb involved. The duration of activity of the disease varied from 3j months to 25 years, average 3-5 years, with no deaths. Our patient was given steroids at a time when the disease had been very active but was beginning to settle and so it is not possible to say what benefit steroids had produced. Winkelmann (1971) feels that in this group of patients with myositis steroids are indicated in the acute phase.
Dr J M Beare: This case illustrates the spectrum of these conditions, ranging from fulminating dermatomyositis at one end to chronic benign morphoea at the other. Dr H R Vickers: Some Members may remember a patient referred by Dr H T Calvert and shown at the Annual Meeting of the British Association of Dermatology in Oxford in 1966. He had very extensive morphcea and eventually died from peritonitis. Postmortem examination showed no evidence of systemic sclerosis in any of his internal organs. Dr H T Calvert: I do not consider that the patient referred to by Dr Vickers is similar to the one now under discussion. He was an example of generalized malignant morphoea where the patient goes steadily downhill and dies before the stage of natural remission can set in, without showing any systemic involvement by scleroderma. If he were re-investigated today we would not find laboratory abnormalities as revealed here. Today's patient is probably an example of mixed connective tissue disease (Sharp et al. 1972, American Journal of Medicine 52, 148; British Medical Journal, 1972, iv, 315 ) -opposed to the triad of scleroderma, dermatomyositis and lupus erythematosus. Professor F F Hellier: Ordinary morphcea usually disappears without showing permanent changes though some forms, such as the 'coup de sabre' type, may leave atrophy. This patient has myositis in addition to the skin changes which might lead to residual atrophy even if the superficial lesions clear up. Dr K D Crow: I agree with Dr Calvert that there is a lethal form of generalized morphoea in which, at autopsy, no systemic lesions are discovered. I have had one such case.
The following cases were also presented: History: From Guyana but living in UK for 15 years. Developed painless papules which had gradually enlarged on face, arms and legs over the last 4-5 months. On direct questioning she denied having any previous illness or taking any form of medication. Only on her third visit, when confronted with the diagnosis, did she admit to having had Hansen's disease at age 13 and having taken dapsone (sent from Guyana) ever since. On examination: Firm, slightly translucent nodule on right cheek and smaller papules on side of nose, left eyebrow, both forearms and calves. No thickened nerves and no neurological deficit. Histopathology: multiple sharply defined noncaseating epithelioid granulomas in dermis around small neurovascular bundles. In Ziehl-Neelsen stain vast numbers of acid-fast bacilli were present in granulomas and throughout dermis.
Discussion
This patient admitted taking dapsone 50 mg twice weekly for at least 20 years and before that to anti-leprosy treatment under the supervision of the local hospital in Guyana. Despite this and in the absence of intercurrent illness or other factors which might alter immunological balance, nodules of leprosy towards the lepromatous end of the spectrum have appeared and it is logical to conclude that dapsone resistance has developed. Dr Stanley Browne: The history of dapsone selfmedication (perhaps irregular or intermittent) over many years and the recent subacute clinical exacerbation, together with the returning presence of a high proportion of morphologically normal M. leprae in the bacilliferous skin lesions, are very suggestive of relapse of near-lepromatous leprosy occurring as the result of the emergence of drug-resistant organisms. The long residence in England and the wilfully misleading history should not obscure the possibility of leprosy. The papules are typical (though not pathognomonic) of clinical relapse: they are small, fleshy and of no special distribution.
If dapsone is being taken regularly and in adequate dosage, and is being absorbed (plasma levels and urine
